{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:59:14Z","timestamp":1792007954830,"version":"4.4.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1038\/s41443-021-00412-z","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T20:14:17Z","timestamp":1612815257000},"page":"710-719","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Contraception across transgender"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6285-8382","authenticated-orcid":false,"given":"Ilaria","family":"Mancini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Alvisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Gava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Seracchioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0061-9834","authenticated-orcid":false,"given":"Maria Cristina","family":"Meriggiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,8]]},"reference":[{"key":"412_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-V). 5th ed. Arlington: American Psychiatric Publishing; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"412_CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1210\/er.2018-00011","volume":"40","author":"G T\u2019Sjoen","year":"2019","unstructured":"T\u2019Sjoen G, Arcelus J, Gooren L, Klink DT, Tangpricha V. Endocrinology of transgender medicine. Endocr Rev. 2019;40:97\u2013117.","journal-title":"Endocr Rev"},{"key":"412_CR3","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","volume":"102","author":"WC Hembree","year":"2017","unstructured":"Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, et al. Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2017;102:3869\u2013903.","journal-title":"J Clin Endocrinol Metab"},{"key":"412_CR4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/jfprhc-2013-100669","volume":"40","author":"C Richards","year":"2014","unstructured":"Richards C, Seal L. Trans people\u2019s reproductive options and outcomes. J Fam Plan Reprod Health Care. 2014;40:245\u20137.","journal-title":"J Fam Plan Reprod Health Care"},{"key":"412_CR5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41585-018-0108-8","volume":"16","author":"M Holmberg","year":"2019","unstructured":"Holmberg M, Arver S, Dhejne C. Supporting sexuality and improving sexual function in transgender persons. Nat Rev Urol. 2019;16:121\u201339.","journal-title":"Nat Rev Urol"},{"key":"412_CR6","doi-asserted-by":"crossref","first-page":"e110016","DOI":"10.1371\/journal.pone.0110016","volume":"9","author":"MK Auer","year":"2014","unstructured":"Auer MK, Fuss J, H\u00f6hne N, Stalla GK, Sievers C. Transgender transitioning and change of self-reported sexual orientation. PLoS ONE. 2014;9:e110016.","journal-title":"PLoS ONE"},{"key":"412_CR7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1542\/peds.2011-1804","volume":"129","author":"AL Roberts","year":"2012","unstructured":"Roberts AL, Rosario M, Corliss HL, Koenen KC, Austin SB. Childhood gender nonconformity: a risk indicator for childhood abuse and posttraumatic stress in youth. Pediatrics. 2012;129:410\u20137.","journal-title":"Pediatrics."},{"key":"412_CR8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2105\/AJPH.2018.304727","volume":"109","author":"JS Becasen","year":"2019","unstructured":"Becasen JS, Denard CL, Mullins MM, Higa DH, Sipe TA. Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006-2017. Am J Public Health. 2019;109:e1\u20138.","journal-title":"Am J Public Health"},{"key":"412_CR9","doi-asserted-by":"crossref","first-page":"100019","DOI":"10.1016\/j.conx.2020.100019","volume":"2","author":"RK Jones","year":"2020","unstructured":"Jones RK, Witwer E, Jerman J. Transgender abortion patients and the provision of transgender-specific care at non-hospital facilities that provide abortions. Contracept X. 2020;2:100019.","journal-title":"Contracept X."},{"key":"412_CR10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.contraception.2018.06.006","volume":"98","author":"A Light","year":"2018","unstructured":"Light A, Wang L-F, Zeymo A, Gomez-Lobo V. Family planning and contraception use in transgender men. Contraception. 2018;98:266\u20139.","journal-title":"Contraception"},{"key":"412_CR11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/andr.12405","volume":"5","author":"F Schneider","year":"2017","unstructured":"Schneider F, Kliesch S, Schlatt S, Neuhaus N. Andrology of male-to-female transsexuals: influence of cross-sex hormone therapy on testicular function. Andrology. 2017;5:873\u201380.","journal-title":"Andrology"},{"key":"412_CR12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/15532739.2011.700873","volume":"13","author":"E Coleman","year":"2011","unstructured":"Coleman E, Bockting W, Botzer M, Cohen-Kettenis P, De Cuypere G, Feldman J, et al. Standards of care for the health of transsexual transgender, and gender-non- conforming people, version 7. Int J Transgenderism. 2011;13:165\u2013232.","journal-title":"Int J Transgenderism"},{"key":"412_CR13","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jsxm.2020.01.012","volume":"17","author":"G T\u2019Sjoen","year":"2020","unstructured":"T\u2019Sjoen G, Arcelus J, De Vries ALC, Fisher AD, Nieder TO, \u00d6zer M, et al. European Society for Sexual Medicine Position Statement \u201cAssessment and Hormonal Management in Adolescent and Adult Trans People, With Attention for Sexual Function and Satisfaction\u201d. J Sex Med. 2020;17:570\u201384.","journal-title":"J Sex Med"},{"key":"412_CR14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MED.0000000000000064","volume":"21","author":"LJ Gooren","year":"2014","unstructured":"Gooren LJ. Management of female-to-male transgender persons: medical and surgical management, life expectancy. Curr Opin Endocrinol Diabetes Obes. 2014;21:233\u20138.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"412_CR15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-8587(16)00036-X","volume":"5","author":"MS Irwig","year":"2017","unstructured":"Irwig MS. Testosterone therapy for transgender men. Lancet Diabetes Endocrinol. 2017;5:301\u201311.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"412_CR16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/cen.12753","volume":"83","author":"MC Meriggiola","year":"2015","unstructured":"Meriggiola MC, Gava G. Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen. Clin Endocrinol. 2015;83:597\u2013606.","journal-title":"Clin Endocrinol"},{"key":"412_CR17","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1111\/jsm.12698","volume":"11","author":"C Pelusi","year":"2014","unstructured":"Pelusi C, Costantino A, Martelli V, Lambertini M, Bazzocchi A, Ponti F, et al. Effects of three different testosterone formulations in female-to-male transsexual persons. J Sex Med. 2014;11:3002\u201311.","journal-title":"J Sex Med"},{"key":"412_CR18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ajog.2019.07.043","volume":"222","author":"C Krempasky","year":"2020","unstructured":"Krempasky C, Harris M, Abern L, Grimstad F. Contraception across the transmasculine spectrum. Am J Obstet Gynecol. 2020;222:134\u201343.","journal-title":"Am J Obstet Gynecol"},{"key":"412_CR19","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.contraception.2016.07.145","volume":"94","author":"A Gomez","year":"2016","unstructured":"Gomez A, Walters P, Dao LT. \u201cTestosterone in a way is birth control\u201d: contraceptive attitudes and experiences among transmasculine and genderqueer young adults. Contraception. 2016;94:422\u20133.","journal-title":"Contraception."},{"key":"412_CR20","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/AOG.0000000000000540","volume":"124","author":"AD Light","year":"2014","unstructured":"Light AD, Obedin-Maliver J, Sevelius JM, Kerns JL. Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstet Gynecol. 2014;124:1120\u20137.","journal-title":"Obstet Gynecol"},{"key":"412_CR21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ajog.2019.12.014","volume":"222","author":"FD Schubert","year":"2020","unstructured":"Schubert FD, Carey JM. Data unclear on pregnancy risk in transmasculine individuals on testosterone. Am J Obstet Gynecol. 2020;222:393\u20134.","journal-title":"Am J Obstet Gynecol"},{"key":"412_CR22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/jcem-69-1-151","volume":"69","author":"T Spinder","year":"1989","unstructured":"Spinder T, Spijkstra JJ, van den Tweel JG, Burger CW, van Kessel H, Hompes PG, et al. The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects. J Clin Endocrinol Metab. 1989;69:151\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"412_CR23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.rbmo.2017.03.008","volume":"34","author":"C De Roo","year":"2017","unstructured":"De Roo C, Lierman S, Tilleman K, Peynshaert K, Braeckmans K, Caanen M, et al. Ovarian tissue cryopreservation in female-to-male transgender people: insights into ovarian histology and physiology after prolonged androgen treatment. Reprod Biomed Online. 2017;34:557\u201366.","journal-title":"Reprod Biomed Online"},{"key":"412_CR24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1745-7262.2006.00204.x","volume":"8","author":"M Berra","year":"2006","unstructured":"Berra M, Armillotta F, D\u2019Emidio L, Costantino A, Martorana G, Pelusi G, et al. Testosterone decreases adiponectin levels in female to male transsexuals. Asian J Androl. 2006;8:725\u20139.","journal-title":"Asian J Androl"},{"key":"412_CR25","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1111\/j.1743-6109.2009.01380.x","volume":"6","author":"AM Perrone","year":"2009","unstructured":"Perrone AM, Cerpolini S, Maria Salfi NC, Ceccarelli C, Badiali de Giorgi L, Formelli G, et al. Effect of long-term testosterone administration on the endometrium of female-to-male (FtM) transsexuals. J Sex Med. 2009;6:3193\u2013200.","journal-title":"J Sex Med"},{"key":"412_CR26","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/AOG.0000000000000692","volume":"125","author":"MB Deutsch","year":"2015","unstructured":"Deutsch MB, Bhakri V, Kubicek K. Effects of cross-sex hormone treatment on transgender women and men. Obstet Gynecol. 2015;125:605\u201310.","journal-title":"Obstet Gynecol"},{"key":"412_CR27","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.fertnstert.2015.02.003","volume":"103","author":"MR Caanen","year":"2015","unstructured":"Caanen MR, Soleman RS, Kuijper EA, Kreukels BPC, De Roo C, Tilleman K, et al. Antimullerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy. Fertil Steril. 2015;103:1340\u20135.","journal-title":"Fertil Steril"},{"key":"412_CR28","first-page":"30134","volume":"S0002-9378","author":"RL Taub","year":"2020","unstructured":"Taub RL, Ellis SA, Neal-Perry G, Magaret AS, Prager SW, Micks EA. The effect of testosterone on ovulatory function in transmasculine individuals. Am J Obstet Gynecol. 2020;S0002-9378:30134\u20134.","journal-title":"Am J Obstet Gynecol"},{"key":"412_CR29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1018638715498","volume":"27","author":"W Futterweit","year":"1998","unstructured":"Futterweit W. Endocrine therapy of transsexualism and potential complications of long-term treatment. Arch Sex Behav. 1998;27:209\u201326.","journal-title":"Arch Sex Behav"},{"key":"412_CR30","doi-asserted-by":"crossref","first-page":"257.e1","DOI":"10.1016\/j.ajog.2018.12.021","volume":"220","author":"FW Grimstad","year":"2019","unstructured":"Grimstad FW, Fowler KG, New EP, Ferrando CA, Pollard RR, Chapman G, et al. Uterine pathology in transmasculine persons on testosterone: a retrospective multicenter case series. Am J Obstet Gynecol. 2019;220:257.e1\u2013257.e7.","journal-title":"Am J Obstet Gynecol"},{"key":"412_CR31","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.tjog.2016.03.004","volume":"55","author":"G Loverro","year":"2016","unstructured":"Loverro G, Resta L, Dellino M, Di Naro E, Cascarano MA, Loverro M, et al. Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals. Taiwan J Obstet Gynecol. 2016;55:686\u201391.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"412_CR32","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4158\/EP15748.DSC","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome: part 1. Endocr Pract. 2015;21:1291\u2013300.","journal-title":"Endocr Pract"},{"key":"412_CR33","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/humrep\/det437","volume":"29","author":"S West","year":"2014","unstructured":"West S, Va\u0308ha\u0308sarja M, Bloigu A, Pouta A, Franks S, Hartikainen AL, et al. The impact of self-reported oligo-amenorrhea and hirsutism on fertility and lifetime reproductive success: results from the Northern Finland Birth Cohort 1966. Hum Reprod. 2014;29:628\u201333.","journal-title":"Hum Reprod."},{"key":"412_CR34","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1365-2265.2009.03563.x","volume":"70","author":"A Castera\u0300s","year":"2009","unstructured":"Castera\u0300s A, De Silva P, Rumsby G, Conway GS. Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate. Clin Endocrinol. 2009;70:833\u20137.","journal-title":"Clin Endocrinol."},{"key":"412_CR35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/AOG.0000000000003308","volume":"134","author":"AR Schwartz","year":"2019","unstructured":"Schwartz AR, Russell K, Gray BA. Approaches to vaginal bleeding and contraceptive counseling in transgender and gender nonbinary patients. Obstet Gynecol. 2019;134:81\u201390.","journal-title":"Obstet Gynecol"},{"key":"412_CR36","doi-asserted-by":"crossref","first-page":"100684","DOI":"10.1016\/j.cppeds.2019.100684","volume":"49","author":"J Mehringer","year":"2019","unstructured":"Mehringer J, Dowshen NL. Sexual and reproductive health considerations among transgender and gender-expansive youth. Curr Probl Pediatr Adolesc Health Care. 2019;49:100684.","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"412_CR37","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1097\/01.AOG.0000533319.47797.7e","volume":"131","author":"L Abern","year":"2018","unstructured":"Abern L, Maguire K. Contraception knowledge in transgender individuals: are we doing enough? Obstet Gynecol. 2018;131:65S.","journal-title":"Obstet Gynecol"},{"key":"412_CR38","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.contraception.2019.07.146","volume":"100","author":"B Stark","year":"2019","unstructured":"Stark B, Hughto JMW, Charlton BM, Deutsch MB, Potter J, Reisner SL. The contraceptive and reproductive history and planning goals of trans-masculine adults: a mixed-methods study. Contraception. 2019;100:468\u201373.","journal-title":"Contraception."},{"key":"412_CR39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.contraception.2016.09.005","volume":"95","author":"D Cipres","year":"2017","unstructured":"Cipres D, Seidman D, Cloniger C 3rd, Nova C, O\u2019Shea A, Obedin-Maliver J. Contraceptive use and pregnancy intentions among transgender men presenting to a clinic for sex workers and their families in San Francisco. Contraception. 2017;95:186\u20139.","journal-title":"Contraception."},{"key":"412_CR40","unstructured":"Trussell J, Aiken ARA, Micks E, Guthrie KA. Efficacy, safety, and personal considerations. In: Hatcher RA, Nelson AL, Trussell J, Cwiak C, Cason P, Policar MS, Edelman A, Aiken ARA, Marrazzo J, Kowal D, editors. Contraceptive technology. 21st ed. New York, NY: Ayer Company Publishers, Inc.; 2018."},{"key":"412_CR41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40695-018-0042-1","volume":"4","author":"A Francis","year":"2018","unstructured":"Francis A, Jasani S, Bachmann G. Contraceptive challenges and the transgender individual. Women\u2019s Midlife Health. 2018;4:12.","journal-title":"Women\u2019s Midlife Health"},{"key":"412_CR42","doi-asserted-by":"crossref","unstructured":"Curtis KM, Jatlaoui TC, Tepper NK, Zapata LB, Horton LG, Jamieson DJ, et al. U.S. Selected practice recommendations for contraceptive use, 2016. MMWR Morb Mortal Wkly Rep. 2016;1\u201366. Accessed 1 Feb 2021.","DOI":"10.15585\/mmwr.rr6504a1"},{"key":"412_CR43","unstructured":"World Health Organization. Medical eligibility criteria for contraceptive use. Third edition, 2004. http:\/\/apps.who.int\/iris\/bitstream\/10665\/42907\/1\/9241562668.pdf. Accessed 28 Jun 2018."},{"key":"412_CR44","doi-asserted-by":"crossref","unstructured":"Faculty of Sexual & Reproductive Healthcare (FSRH). UK Medical Eligibility Criteria for Contraceptive Use (UKMEC) 2016. 2016. http:\/\/www.fsrh.org\/standards-and-guidance\/ukmedical-eligibility-criteria-for-contraceptive-use\/.","DOI":"10.12968\/indn.2016.13.16"},{"key":"412_CR45","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s11606-010-1610-8","volume":"26","author":"CK Bates","year":"2011","unstructured":"Bates CK, Carroll N, Potter J. The challenging pelvic examination. J Gen Intern Med. 2011;26:651\u20137.","journal-title":"J Gen Intern Med"},{"key":"412_CR46","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1093\/humrep\/dew222","volume":"31","author":"M Ali","year":"2016","unstructured":"Ali M, Akin A, Bahamondes L, Brache V, Habib N, Landoulsi S, et al. WHO study group on subdermal contraceptive implants for women. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant. Hum Reprod. 2016;31:2491\u20138.","journal-title":"Hum Reprod."},{"key":"412_CR47","unstructured":"Wolters Kluwer Health, Inc. Etonogestrel implant. Lexi-drugs. Lexicomp. http:\/\/online.lexi.com. Accessed 2 May 2019."},{"key":"412_CR48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13625180801959931","volume":"13","author":"D Mansour","year":"2008","unstructured":"Mansour D, Korver T, Marintcheva- Petrova M, Fraser IS. The effects of Implanon on menstrual bleeding patterns. Eur J Contracept Reprod Health Care. 2008;13:13\u201328.","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"412_CR49","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.contraception.2004.11.007","volume":"71","author":"S Funk","year":"2005","unstructured":"Funk S, Miller MM, Mishell DR, Archer DF, Poindexter A, Schmidt J, et al. Safety and efficacy of implanon, a single-rod implant- able contraceptive containing etonogestrel. Contraception. 2005;71:319\u201326.","journal-title":"Contraception"},{"key":"412_CR50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jpag.2019.05.010","volume":"33","author":"JK Hodax","year":"2020","unstructured":"Hodax JK, Wagner J, Sackett-Taylor AC, Rafferty J, Forcier M. Medical options for care of gender diverse and transgender youth. J Pediatr Adolesc Gynecol. 2020;33:3\u20139.","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"412_CR51","unstructured":"Wolters Kluwer Health, Inc. Medroxyprogesterone acetate. Lexi-drugs. Lexicomp. http:\/\/online.lexi.com. Accessed 2 May 2019."},{"key":"412_CR52","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(19)31288-7","volume":"394","author":"Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium.","year":"2019","unstructured":"Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial [published correction appears in Lancet. 2019 Jul 27;394(10195):302]. Lancet. 2019;394:303\u201313.","journal-title":"Lancet"},{"key":"412_CR53","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.mayocp.2015.05.012","volume":"90","author":"J Baillargeon","year":"2015","unstructured":"Baillargeon J, Urban RJ, Morgentaler A, Glueck CJ, Baillargeon G, Sharma G, et al. Risk of venous thromboembolism in men receiving testosterone therapy. Mayo Clin Proc. 2015;90:1038\u201345.","journal-title":"Mayo Clin Proc"},{"key":"412_CR54","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","volume":"374","author":"PJ Snyder","year":"2016","unstructured":"Snyder PJ, Ellenberg SS, Farrar JT. Effects of testosterone treatment in older men. N Engl J Med. 2016;374:611\u201324.","journal-title":"N Engl J Med"},{"key":"412_CR55","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ajh.24593","volume":"92","author":"JJ Shatzel","year":"2017","unstructured":"Shatzel JJ, Connelly KJ, DeLoughery TG. Thrombotic issues in transgender medicine: a review. Am J Hematol. 2017;92:204\u20138.","journal-title":"Am J Hematol"},{"key":"412_CR56","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/jmwh.12962","volume":"64","author":"D Boudreau","year":"2019","unstructured":"Boudreau D, Mukerjee R. Contraception care for transmasculine individuals on testosterone therapy. J Midwifery Women\u2019s Health. 2019;64:395\u2013402.","journal-title":"J Midwifery Women\u2019s Health"},{"key":"412_CR57","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/oxfordjournals.bmb.a072606","volume":"49","author":"HM Fraser","year":"1993","unstructured":"Fraser HM. GnRH analogues for contraception. Br Med Bull. 1993;49:62\u201372.","journal-title":"Br Med Bull"},{"key":"412_CR58","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/AOG.0000000000003134","volume":"133","author":"American College of Obstetricians and Gynecologists","year":"2019","unstructured":"American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 208 Summary: Benefits and Risks of Sterilization. Obstet Gynecol. 2019;133:592\u20134.","journal-title":"Obstet Gynecol."},{"key":"412_CR59","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jadohealth.2017.11.306","volume":"63","author":"D Chen","year":"2018","unstructured":"Chen D, Matson M, Macapagal K, Johnson EK, Rosoklija I, Finlayson C, et al. Attitudes toward fertility and reproductive health among transgender and gender-nonconforming adolescents. J Adolesc Health. 2018;63:62\u20138.","journal-title":"J Adolesc Health"},{"key":"412_CR60","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/jfprhc-2017-101809","volume":"43","author":"K Jones","year":"2017","unstructured":"Jones K, Wood M, Stephens L. Contraception choices for transgender males. J Fam Plan Reprod Health Care. 2017;43:239\u201340.","journal-title":"J Fam Plan Reprod Health Care"},{"key":"412_CR61","unstructured":"Lexicomp. Testosterone: drug information. Alphen aan den Rijn, The Netherlands: Wolters Kluwer; 2018. Accessed 10 Oct 2018."},{"key":"412_CR62","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.fertnstert.2019.09.002","volume":"113","author":"J Defreyne","year":"2020","unstructured":"Defreyne J, Van Schuylenbergh J, Motmans J, Tilleman KL, T\u2019Sjoen GGR. Parental desire and fertility preservation in assigned female at birth transgender people living in Belgium. Fertil Steril. 2020;113:149\u2013157.e2.","journal-title":"Fertil Steril"},{"key":"412_CR63","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/cen.12754","volume":"83","author":"MC Meriggiola","year":"2015","unstructured":"Meriggiola MC, Gava G. Endocrine care of transpeople part II. A review of cross-sex hormonal treatments, outcomes and adverse effects in transwomen. Clin Endocrinol . 2015;83:607\u201315.","journal-title":"Clin Endocrinol"},{"key":"412_CR64","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/and.12150","volume":"46","author":"H Asscheman","year":"2014","unstructured":"Asscheman H, T\u2019Sjoen G, Lemaire A, Mas M, Meriggiola MC, Mueller A, et al. Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review. Andrologia. 2014;46:791\u20135.","journal-title":"Andrologia."},{"key":"412_CR65","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/jsm.12571","volume":"11","author":"K Wierckx","year":"2014","unstructured":"Wierckx K, Van Caenegem E, Schreiner T, Haraldsen I, Fisher AD, Toye K, et al. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence [published correction appears in J Sex Med. 2016;13(4):732]. J Sex Med. 2014;11:1999\u20132011.","journal-title":"J Sex Med."},{"key":"412_CR66","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S2213-8587(17)30068-2","volume":"5","author":"Y Mamoojee","year":"2017","unstructured":"Mamoojee Y, Seal LJ, Quinton R. Transgender hormone therapy: understanding international variation in practice. Lancet Diabetes Endocrinol. 2017;5:243\u20136.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"412_CR67","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(06)68614-5","volume":"367","author":"PY Liu","year":"2006","unstructured":"Liu PY, Swerdloff RS, Christenson PD, Handelsmann DJ, Wang C. Hormonal Male Contraception Summit Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet. 2006;367:1412\u201320.","journal-title":"Lancet"},{"key":"412_CR68","doi-asserted-by":"crossref","first-page":"204201881983484","DOI":"10.1177\/2042018819834846","volume":"10","author":"G Gava","year":"2019","unstructured":"Gava G, Meriggiola MC. Update on male hormonal contraception. Ther Adv Endocrinol Metab. 2019;10:2042018819834846.","journal-title":"Ther Adv Endocrinol Metab."},{"key":"412_CR69","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ecl.2019.02.003","volume":"48","author":"MF Neblett 2nd","year":"2019","unstructured":"Neblett MF 2nd, Hipp HS. Fertility considerations in transgender persons. Endocrinol Metab Clin N Am. 2019;48:391\u2013402.","journal-title":"Endocrinol Metab Clin N Am"},{"key":"412_CR70","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF00735221","volume":"411","author":"A Sapino","year":"1987","unstructured":"Sapino A, Pagani A, Godano A, Bussolati G. Effects of estrogens on the testis of transsexuals: a pathological and immunocytochemical study. Virchows Arch A Pathol Anat Histopathol. 1987;411:409\u201314.","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"412_CR71","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0015-0282(16)55271-6","volume":"58","author":"H L\u00fcbbert","year":"1992","unstructured":"L\u00fcbbert H, Leo-Rossberg I, Hammerstein J. Effects of ethinyl estradiol on semen quality and various hormonal parameters in a eugonadal male. Fertil Steril. 1992;58:603\u20138.","journal-title":"Fertil Steril"},{"key":"412_CR72","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00215444","volume":"251","author":"C Schulze","year":"1988","unstructured":"Schulze C. Response of the human testis to long-term estrogen treatment: morphology of Sertoli cells, Leydig cells and spermatogonial stem cells. Cell Tissue Res. 1988;251:31\u201343.","journal-title":"Cell Tissue Res"},{"key":"412_CR73","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0039-128X(77)80019-6","volume":"30","author":"LJ Rodriguez-Rigau","year":"1977","unstructured":"Rodriguez-Rigau LJ, Tcholakian RK, Smith KD, Steinberger E. In vitro steroid metabolic studies in human testes. II: metabolism of cholesterol, pregnenolone, progesterone, androstenedione and testosterone by testes of an estrogen-treated man. Steroids. 1977;30:729\u201339.","journal-title":"Steroids"},{"key":"412_CR74","first-page":"347","volume":"16","author":"D Thiagaraj","year":"1987","unstructured":"Thiagaraj D, Gunasegaram R, Loganath A, Peh KL, Kottegoda SR, Ratnam SS. Histopathology of the testes from male transsexuals on oestrogen therapy. Ann Acad Med Singap. 1987;16:347\u20138.","journal-title":"Ann Acad Med Singap"},{"key":"412_CR75","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1439-0272.1979.tb02232.x","volume":"11","author":"AF Payer","year":"1979","unstructured":"Payer AF, Meyer WJ 3rd, Walker PA. The ultrastructural response of human Leydig cells to exogenous estrogens. Andrologia. 1979;11:423\u201336.","journal-title":"Andrologia."},{"key":"412_CR76","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1111\/jsm.13022","volume":"12","author":"F Schneider","year":"2015","unstructured":"Schneider F, Neuhaus N, Wistuba J, Zitzmann M, Hess J, Mahler D, et al. Testicular functions and clinical characterization of patients with gender dysphoria (GD) undergoing sex reassignment surgery (SRS). J Sex Med. 2015;12:2190\u2013200.","journal-title":"J Sex Med"},{"key":"412_CR77","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.humpath.2018.03.007","volume":"76","author":"A Matoso","year":"2018","unstructured":"Matoso A, Khandakar B, Yuan S, Wo T, Wang LJ, Lombardo KA, et al. Spectrum of findings in orchiectomy specimens of persons undergoing gender confirmation surgery. Hum Pathol. 2018;76:91\u20139.","journal-title":"Hum Pathol"},{"key":"412_CR78","doi-asserted-by":"crossref","DOI":"10.1038\/srep39931","volume":"7","author":"M Leavy","year":"2017","unstructured":"Leavy M, Trottmann M, Liedl B, Reese S, Stief C, Freitag B, et al. Effects of elevated beta-estradiol levels on the functional morphology of the testis\u2014new insights. Sci Rep. 2017;7:39931.","journal-title":"Sci Rep"},{"key":"412_CR79","doi-asserted-by":"crossref","first-page":"7919481","DOI":"10.1155\/2018\/7919481","volume":"2018","author":"S Jindarak","year":"2018","unstructured":"Jindarak S, Nilprapha K, Atikankul T, Angspatt A, Pungrasmi P, Iamphongsai S, et al. Spermatogenesis abnormalities following hormonal therapy in transwomen. Biomed Res Int. 2018;2018:7919481.","journal-title":"Biomed Res Int"},{"key":"412_CR80","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1001\/jama.2018.6514","volume":"319","author":"J Fainberg","year":"2018","unstructured":"Fainberg J, Kashanian JA. Vasectomy. JAMA. 2018;319:2450.","journal-title":"JAMA."},{"key":"412_CR81","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.jsxm.2019.08.009.","volume":"16","author":"SG Haley","year":"2019","unstructured":"Haley SG, Tordoff DM, Kantor AZ, Crouch JM, Ahrens KR. Sex education for transgender and non-binary youth: previous experiences and recommended content. J Sex Med. 2019;16:1834\u201348. https:\/\/doi.org\/10.1016\/j.jsxm.2019.08.009.","journal-title":"J Sex Med"},{"key":"412_CR82","unstructured":"James SE, Herman JL, Rankin S, Keisling M, Mottet L, Anafi M. The Report of the 2015 U.S. Transgender Survey. Washington, DC: National Center for Transgender Equality. 2016."},{"key":"412_CR83","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/vio.2017.0041","volume":"5","author":"T Goldenberg","year":"2018","unstructured":"Goldenberg T, Jadwin-Cakmak L, Harper GW. Intimate partner violence among transgender youth: associations with intra-personal and structural factors. Violence Gend. 2018;5:19\u201325.","journal-title":"Violence Gend"},{"key":"412_CR84","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jadohealth.2005.03.023","volume":"38","author":"R Garofalo","year":"2006","unstructured":"Garofalo R, Deleon J, Osmer E, Doll M, Harper GW. Overlooked, misunderstood and at-risk: exploring the lives and HIV risk of ethnic minority male-to-female transgender youth. J Adolesc Health. 2006;38:230\u20136.","journal-title":"J Adolesc Health."},{"key":"412_CR85","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2265.1984.tb00066.x","volume":"20","author":"S Bhasin","year":"1984","unstructured":"Bhasin S, Heber D, Steiner B, Peterson M, Blaisch B, Campfield LA, et al. Hormonal effects of GnRH agonist in the human male: II. Testosterone enhances gonadotrophin suppression induced by GnRH agonist. Clin Endocrinol (Oxf). 1984;20:119\u201328.","journal-title":"Clin Endocrinol (Oxf)."},{"key":"412_CR86","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.whi.2018.03.002","volume":"28","author":"E Wingo","year":"2018","unstructured":"Wingo E, Ingraham N, Roberts SCM. Reproductive health care priorities and barriers to effective care for LGBTQ people assigned female at birth: a qualitative study. Women\u2019s Health Issues. 2018;28:350\u20137.","journal-title":"Women\u2019s Health Issues"},{"key":"412_CR87","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","volume":"83","author":"J Trussell","year":"2011","unstructured":"Trussell J. Contraceptive failure in the United States. Contraception. 2011;83:397\u2013404.","journal-title":"Contraception"},{"key":"412_CR88","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/00003495-199855060-00019","volume":"55","author":"AJ Coukell","year":"1998","unstructured":"Coukell AJ, Balfour JA. Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability. Drugs. 1998;55:861\u201387.","journal-title":"Drugs"},{"key":"412_CR89","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2001-18642","volume":"19","author":"KR Meckstroth","year":"2001","unstructured":"Meckstroth KR, Darney PD. Implant contraception. Semin Reprod Med. 2001;19:339\u201354.","journal-title":"Semin Reprod Med"},{"key":"412_CR90","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2011.12.003","volume":"97","author":"K Gemzell-Danielsson","year":"2012","unstructured":"Gemzell-Danielsson K, Schellschmidt I, Apter D. A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena. Fertil Steril. 2012;97:616e22.","journal-title":"Fertil Steril"},{"key":"412_CR91","doi-asserted-by":"crossref","first-page":"520","DOI":"10.5603\/GP.2019.0091","volume":"90","author":"A Fuchs","year":"2019","unstructured":"Fuchs A, Maton\u00f3g A, Sieradzka P, Pilarska J, Hauzer A, Czech I, et al. Anti-androgenic therapy in young patients and its impact on intensity of hirsutism, acne, menstrual pain intensity and sexuality - a preliminary study. Ginekol Pol. 2019;90:520\u20136.","journal-title":"Ginekol Pol."},{"key":"412_CR92","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1517\/14656566.2014.888414","volume":"15","author":"CJ Jeng","year":"2014","unstructured":"Jeng CJ, Chuang L, Shen J. A comparison of progestogens or oral contraceptives and gonadotropin-releasing hormone agonists for the treatment of endometriosis: a systematic review. Expert Opin Pharmacother. 2014;15:767\u201373.","journal-title":"Expert Opin Pharmacother"},{"key":"412_CR93","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/00003081-199538040-00017","volume":"38","author":"SC Stone","year":"1995","unstructured":"Stone SC. Desogestrel. Clin Obstet Gynecol. 1995;38:821\u20138.","journal-title":"Clin Obstet Gynecol"},{"key":"412_CR94","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/AOG.0000000000003089","volume":"133","author":"S Dianat","year":"2019","unstructured":"Dianat S, Fox E, Ahrens KA, Upadhyay UD, Zlidar VM, Gallo MF, et al. Side effects and health benefits of depot medroxyprogesterone acetate: a systematic review. Obstet Gynecol. 2019;133:332\u201341.","journal-title":"Obstet Gynecol."},{"key":"412_CR95","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ajog.2016.12.008","volume":"216","author":"RE Zigler","year":"2017","unstructured":"Zigler RE, McNicholas C. Unscheduled vaginal bleeding with progestin-only contraceptive use. Am J Obstet Gynecol. 2017;216:443\u201350.","journal-title":"Am J Obstet Gynecol"},{"key":"412_CR96","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0010-7824(91)90078-T","volume":"44","author":"IC Chi","year":"1991","unstructured":"Chi IC. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs. Contraception. 1991;44:573\u201388.","journal-title":"Contraception"},{"key":"412_CR97","volume":"2","author":"A Lethaby","year":"2019","unstructured":"Lethaby A, Wise MR, Weterings MA, Rodriguez MB, Brown J. Combined hormonal contraceptives for heavy menstrual bleeding. Cochrane Database Syst Rev. 2019;2:CD000154.","journal-title":"Cochrane Database Syst Rev"},{"key":"412_CR98","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.contraception.2011.04.002","volume":"84","author":"D Mansour","year":"2011","unstructured":"Mansour D, Gemzell-Danielsson K, Inki P, Jensen JT. Fertility after discontinuation of contraception: a comprehensive review of the literature. Contraception. 2011;84:465\u201377.","journal-title":"Contraception"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41443-021-00412-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-021-00412-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-021-00412-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T13:30:36Z","timestamp":1638279036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-021-00412-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,8]]},"references-count":98,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["412"],"URL":"https:\/\/doi.org\/10.1038\/s41443-021-00412-z","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,8]]},"assertion":[{"value":"2 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}